Mortgage REIT ETF Market Vectors (MORT) 22.03

New Post Public Reply Private Reply Replies (0) Message Board

Sep 19, 2016 at 3:11 PM

Mortgage REIT ETF Market Vectors (MORT) 22.03 $MORT

Mortgage REIT Income ETF -- Insider Buying Index Registering 21.8%
ETFChannel.com - Wed Aug 24, 8:31AM CDT
A look at the weighted underlying holdings of the Mortgage REIT Income ETF shows an impressive 21.8% of holdings on a weighted basis have experienced insider buying within the past six months. Redwood Trust Inc.
MORT: 22.03 (+0.19)

Dull Mortgage REIT Earnings: ETFs in Focus
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 10:11AM CDT
A low interest rate environment is expected to benefit the performance of mortgage REIT ETFs.
NLY: 10.53 (+0.06), MORT: 22.03 (+0.19), REM: 10.65 (+0.12), AGNC: 19.29 (+0.14)

Red-Hot Income ETFs Post Fed Meet
Sweta Killa - Zacks Investment Research - Thu Jun 16, 9:02AM CDT
We have highlighted four high income areas and their ETFs that would be in focus and are big movers from the Fed decision.
JNK: 36.21 (+0.07), HYG: 86.02 (+0.11), DVY: 85.63 (+0.61), MORT: 22.03 (+0.19), REM: 10.65 (+0.12), VIG: 83.12 (+0.39), VPU: 109.20 (+0.95), XLU: 49.68 (+0.42), SDY: 83.20 (+0.56)

15 Most Read ETF Articles of the Week (May 16-20)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri May 20, 4:34PM CDT
Each day ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the Top 15 Most Viewed Articles of the Week on ETF Trends, May 16-20, 2016. Click...
USO: 10.04 (+0.04), SCHZ: 53.36 (+0.01), MLN: 20.77 (-0.03), HYMB: 59.38 (+0.02), HYD: 32.26 (+0.01), FBT: 99.66 (+0.38), GREK: 7.01 (+0.01), XBI: 66.41 (+1.70), IBB: 292.74 (+1.11), BNO: 13.55 (+0.05), BNDX: 55.57 (+0.01), PPLT: 98.30 (+0.75), PGX: 15.08 (-0.01), SGOL: 127.84 (+0.29), FVD: 26.94 (+0.15), BSV: 80.72 (unch), RVNU: 27.52 (unch), MORT: 22.03 (+0.19), REM: 10.65 (+0.12), GLD: 125.36 (+0.30), PFF: 39.40 (+0.05), AGG: 111.76 (-0.04), IAU: 12.66 (+0.02), BND: 83.62 (-0.03)

15 Most Read ETF Articles of the Week (May 9-13)
etftrends@etftrends.com (ETF Trends) - ETF Trends - Fri May 13, 5:44PM CDT
Each day ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the Top 15 Most Viewed Articles of the Week on ETF Trends, May 9-13, 2016. Click...
SPLV: 41.32 (+0.20), IST: 24.18 (+0.15), OUNZ: 13.02 (+0.04), SIVR: 18.77 (+0.37), SCHH: 42.11 (+0.07), SGOL: 127.84 (+0.29), SOYB: 18.73 (+0.08), JPGE: 52.23 (+0.44), SLV: 18.21 (+0.35), SDOG: 41.21 (+0.21), FXG: 46.07 (+0.14), USMV: 45.28 (+0.17), XTL: 64.99 (+0.75), DVY: 85.63 (+0.61), REZ: 64.57 (+0.53), RWR: 96.13 (+0.70), PBJ: 32.85 (+0.07), FCOM: 29.73 (+0.04), FENY: 18.93 (+0.05), ECON: 24.45 (+0.23), IAU: 12.66 (+0.02), VYM: 71.51 (+0.26), AMLP: 12.31 (+0.19), FRI: 23.97 (+0.19), IDOG: 23.62 (+0.11), VIG: 83.12 (+0.39), JPEM: 48.06 (+0.26), XLP: 52.88 (+0.09), IYZ: 32.29 (+0.11), FSTA: 31.71 (+0.09), MORT: 22.03 (+0.19), REM: 10.65 (+0.12), IYR: 80.01 (+0.63), EMB: 115.80 (+0.45), ZSL: 28.55 (-1.21), VNQ: 85.62 (+0.65), JPIN: 50.99 (+0.35), XLE: 67.78 (+0.33), IYK: 113.78 (+0.42), KXI: 98.02 (+0.49), VDE: 93.92 (+0.43), VDC: 136.73 (+0.33), IPS: 43.23 (+0.43), DBA: 20.41 (+0.08), IYE: 37.55 (+0.17), ICF: 104.26 (+0.80), GLD: 125.36 (+0.30), VOX: 94.18 (+0.11), CORN: 18.79 (+0.07), IXP: 60.77 (+0.13), KBWY: 35.70 (+0.28)

ETFs to Watch Post Dull Mortgage REIT Earnings
Zacks Equity Research - Zacks Investment Research - Wed May 11, 12:04PM CDT
A low interest rate environment is expected to benefit the performance of mortgage REIT ETFs.
NLY: 10.53 (+0.06), MORT: 22.03 (+0.19), REM: 10.65 (+0.12), AGNC: 19.29 (+0.14)

A+ Real Estate ETFs to Capitalize on a Dovish Fed
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 09, 7:15AM CDT
Real estate investment trusts and related exchange traded funds (ETFs) are capitalizing on the low interest-rate environment, and the market could find further support ahead as REITs become the newest S&P 500 sector. REITs are firms that trade...
MORT: 22.03 (+0.19), RWX: 40.71 (+0.38), REM: 10.65 (+0.12), IYR: 80.01 (+0.63), VNQI: 55.10 (+0.45)

44 Best REITs ETFs to Generate Yields
etftrends@etftrends.com (ETF Trends) - ETF Trends - Thu May 05, 3:39PM CDT
Real estate investment trusts (REITs) and sector-related exchange traded funds (ETFs) are a good source of attractive payouts in a low-yield environment. REITs are securities that trade like a stock and invest in real estate directly through property...
FRI: 23.97 (+0.19), WREI: 48.63 (+0.63), GRI: 44.71 (+0.42), SCHH: 42.11 (+0.07), DRV: 12.74 (-0.28), DRW: 28.62 (+0.23), IFGL: 29.74 (+0.20), MORT: 22.03 (+0.19), REK: 17.40 (-0.08), REM: 10.65 (+0.12), DRN: 23.35 (+0.49), IYR: 80.01 (+0.63), VNQI: 55.10 (+0.45), URE: 120.01 (+1.81), SRET: 14.98 (+0.16), VNQ: 85.62 (+0.65), SRS: 35.45 (-0.56), IFEU: 36.40 (+0.09), REZ: 64.57 (+0.53), FFR: 45.58 (+0.48), WPS: 37.34 (+0.22), TAO: 22.93 (+0.28), RWR: 96.13 (+0.70), EMRE: 23.14 (-0.03), GQRE: 59.21 (+0.06), ICF: 104.26 (+0.80), ROOF: 27.29 (+0.19), RWO: 48.97 (+0.36), DBRE: 23.80 (unch), RWX: 40.71 (+0.38), PSR: 78.21 (+0.72), KBWY: 35.70 (+0.28)

3 ETF Winners Post Fed Rate Hike
Zacks Equity Research - Zacks Investment Research - Wed Dec 23, 11:29AM CST
These ETFs registered healthy gains in the post rate-hike period.
MORT: 22.03 (+0.19), XBI: 66.41 (+1.70), TAN: 19.61 (-0.05)

2 ETFs to Watch on Lackluster Mortgage REIT Earnings
Zacks Equity Research - Zacks Investment Research - Fri Nov 06, 11:28AM CST
Dull third-quarter results of these mREITs are expected to worsen the performance of REIT ETFs with significant exposure to them.
NLY: 10.53 (+0.06), MORT: 22.03 (+0.19), REM: 10.65 (+0.12), AGNC: 19.29 (+0.14)

Reasons to Believe in mREIT ETFs
ETFtrends.com - ETF Trends - Wed Nov 04, 7:30AM CST
The iShares Mortgage Real Estate Capped ETF (NYSEArca: REM ) and the rival Market Vectors Mortgage REIT Income ETF (NYSEArca: MORT ) have been challenged this year by speculation that the Federal Reserve will soon raise interest rates, but that...
MORT: 22.03 (+0.19), REM: 10.65 (+0.12)

mREIT ETFs got Some Temporary Fed Relief
ETFtrends.com - ETF Trends - Mon Sep 21, 6:30AM CDT
Exchange traded funds holding high-yield mortgage real estate investment trusts (mREITs) got some welcomed relief last week when the Federal Reserve opted to maintain its zero interest rate policy. That does not mean the iShares Mortgage Real...
MORT: 22.03 (+0.19), REM: 10.65 (+0.12)

Watch These Income ETFs as Fed Meets
Sweta Killa - Zacks Investment Research - Wed Sep 16, 10:15AM CDT
Income-investing corner of the world could see heavy trading post Fed meeting.
JNK: 36.21 (+0.07), HYG: 86.02 (+0.11), DVY: 85.63 (+0.61), MORT: 22.03 (+0.19), REM: 10.65 (+0.12), VIG: 83.12 (+0.39), VPU: 109.20 (+0.95), XLU: 49.68 (+0.42), SDY: 83.21 (+0.57)

Opportunity With Some Beaten Up Income ETFs
ETFtrends.com - ETF Trends - Tue Sep 08, 8:00AM CDT
Few income-generating asset classes are as sensitive to fluctuations in interest rates as are mortgage real estate investment trusts (mREITs), so it is not surprising that with all the talk of the Federal Reserve raising interest rates this year that...
MORT: 22.03 (+0.19), REM: 10.65 (+0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...